Disclosed are compounds, which are bradykinin antagonists and are useful to treat diseases or relieve adverse symptoms associated with disease conditions in mammals mediated by bradykinin. Certain of the compounds exhibit increased potency and are expected to also exhibit an increased duration of action.

 
Web www.patentalert.com

< Method for thickening aqueous systems using hydrophilic polyurethanes

< Black dye mixtures of fiber-reactive AZO dyes and use thereof for dyeing material containing hydroxy- and/or carboxamido groups

> Process for electroplating metal into microscopic recessed features

> Chemical compositions comprising crystalline colloidal arrays
~ 00276